• Influenza Virus Type A and B, SARS-CoV-2 (COVID-19) Antibody or Antigen
  • Estradiol, Serum
  • Estrogen/Progesterone Receptor, IHC
  • MGMT (O-6-methylguanine-DNA methyltransferase) Methylation Detection
  • Coagulation Factor XI Inhibitor Screen, Plasma
  • Erythropoietin
  • Megaloblastic anemia (Myelodysplastic syndrome)
  • Aldosterone with Sodium, 24 Hour, Urine
  • Methadone and Metabolites, Confirmation, Urine
  • Vitamin B2 (Riboflavin)
  • LDS
  • Sign up
  • Log in
  • LDS
  • /Medical Tests
  • /Nudix Hydrolase 15 (NUDT15) Gene Mutation Analysis
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References

Nudix Hydrolase 15 (NUDT15) Gene Mutation Analysis
Medical Test

Turnaround Time
Access to Nudix Hydrolase 15 (NUDT15) Gene Mutation Analysis is restricted.